Evidence map›Paper›PMID 40579141›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2025

[Correlations of immune cell infiltration characteristics with clinicopathological parameters in patients with clear cell renal cell carcinoma].

Huaxuan Zhao, Guichao Zhang, Jiarong Liu, Futian Mo, Taoen Li, Chengyong Lei, Shidong Lü

Abstract readEnglish Abstract
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Huaxuan ZhaoSchool of Stomatology, Southern Medical University, Guangzhou 510515, China.
Guichao ZhangSchool of Stomatology, Southern Medical University, Guangzhou 510515, China.
Jiarong LiuDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Futian MoDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Taoen LiDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Chengyong LeiDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Shidong LüDepartment of Urology, Guangdong Provincial People's Hospital, Guangzhou 510080, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo investigate the characteristics of immune cell infiltration in tumor samples from Chinese patients with clear cell renal cell carcinoma (ccRCC) and the correlation of immune cell infiltration with tumor stage and response to immunotherapy.

methodsTumor samples and clinicopathological data were collected from 154 ccRCC patients treated in Nanfang Hospital, Southern Medical University from October, 2020 to October, 2023. The immune cell types infiltrating the tumor tissues were identified using immunohistochemistry and immunofluorescence staining, and their correlations with the patients' clinicopathological characteristics were analyzed. Patient-derived tumor tissue fragment models (PDTF) models, constructed using tumor tissues from 22 patients, were treated with PD-1 monoclonal antibody, and T cell activation was detected using flow cytometry to assess the patients' responses to immunotherapy.

resultsIn Chinese ccRCC patients included in this study, CD8

conclusionsThe infiltrating immune cells are heterogeneous in Chinese ccRCC patients, and immune cell infiltration characteristics are closely correlated with clinicopathological parameters of the patients.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsLymphocytes, Tumor-InfiltratingAdultAgedCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesFemaleHumansImmunotherapyMaleMiddle AgedNeoplasm StagingProgrammed Cell Death 1 ReceptorT-LymphocytesProgrammed Cell Death 1 Receptorclear cell renal cell carcinomapatient-derived tumor tissue fragment modelstumor-infiltrating lymphocytes

Identifiers

PMID40579141
PMCPMC12204842

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.